<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2020-10-07" version="213">
<accession>P35354</accession>
<accession>A8K802</accession>
<accession>Q16876</accession>
<name>PGH2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Prostaglandin G/H synthase 2</fullName>
<ecNumber evidence="17 24 25">1.14.99.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cyclooxygenase-2</fullName>
<shortName>COX-2</shortName>
</alternativeName>
<alternativeName>
<fullName>PHS II</fullName>
</alternativeName>
<alternativeName>
<fullName>Prostaglandin H2 synthase 2</fullName>
<shortName>PGH synthase 2</shortName>
<shortName>PGHS-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Prostaglandin-endoperoxide synthase 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTGS2</name>
<name type="synonym">COX2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="9049" last="9054">
<title>Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.</title>
<authorList>
<person name="Jones D.A."/>
<person name="Carlton D.P."/>
<person name="McIntyre T.M."/>
<person name="Zimmerman G.A."/>
<person name="Prescott S.M."/>
</authorList>
<dbReference type="PubMed" id="8473346"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Endothelial cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="7384" last="7388">
<title>Human cyclooxygenase-2 cDNA.</title>
<authorList>
<person name="Hla T."/>
<person name="Neilson K."/>
</authorList>
<dbReference type="PubMed" id="1380156"/>
<dbReference type="DOI" id="10.1073/pnas.89.16.7384"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Endothelial cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="221" first="889" last="897">
<title>Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.</title>
<authorList>
<person name="Kosaka T."/>
<person name="Miyata A."/>
<person name="Ihara H."/>
<person name="Hara S."/>
<person name="Sugimoto T."/>
<person name="Takeda O."/>
<person name="Takahashi E."/>
<person name="Tanabe T."/>
</authorList>
<dbReference type="PubMed" id="8181472"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.tb18804.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="Biochem. J." volume="302" first="723" last="727">
<title>Structure of the human cyclo-oxygenase-2 gene.</title>
<authorList>
<person name="Appleby S.B."/>
<person name="Ristimaki A."/>
<person name="Neilson K."/>
<person name="Narko K."/>
<person name="Hla T."/>
</authorList>
<dbReference type="PubMed" id="7945196"/>
<dbReference type="DOI" id="10.1042/bj3020723"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2003-11" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Sharma S.V."/>
<person name="Aronstam R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS HIS-228; ALA-428; ALA-511 AND ARG-587</scope>
</reference>
<reference key="7">
<citation type="submission" date="2003-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Synovium</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1994" name="Biochim. Biophys. Acta" volume="1209" first="130" last="139">
<title>Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.</title>
<authorList>
<person name="Barnett J."/>
<person name="Chow J."/>
<person name="Ives D."/>
<person name="Chiou M."/>
<person name="Mackenzie R."/>
<person name="Osen E."/>
<person name="Nguyen B."/>
<person name="Tsing S."/>
<person name="Bach C."/>
<person name="Freire J."/>
</authorList>
<dbReference type="PubMed" id="7947975"/>
<dbReference type="DOI" id="10.1016/0167-4838(94)90148-1"/>
</citation>
<scope>CHARACTERIZATION</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="24019" last="24023">
<title>Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2.</title>
<authorList>
<person name="Kulmacz R.J."/>
<person name="Wang L.H."/>
</authorList>
<dbReference type="PubMed" id="7592599"/>
<dbReference type="DOI" id="10.1074/jbc.270.41.24019"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="Biochemistry" volume="36" first="1836" last="1845">
<title>Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2.</title>
<authorList>
<person name="Xiao G."/>
<person name="Tsai A.L."/>
<person name="Palmer G."/>
<person name="Boyar W.C."/>
<person name="Marshall P.J."/>
<person name="Kulmacz R.J."/>
</authorList>
<dbReference type="PubMed" id="9048568"/>
<dbReference type="DOI" id="10.1021/bi962476u"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="21565" last="21574">
<title>Mutational analysis of the role of the distal histidine and glutamine residues of prostaglandin-endoperoxide synthase-2 in peroxidase catalysis, hydroperoxide reduction, and cyclooxygenase activation.</title>
<authorList>
<person name="Landino L.M."/>
<person name="Crews B.C."/>
<person name="Gierse J.K."/>
<person name="Hauser S.D."/>
<person name="Marnett L.J."/>
</authorList>
<dbReference type="PubMed" id="9261177"/>
<dbReference type="DOI" id="10.1074/jbc.272.34.21565"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF GLN-189 AND HIS-193</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="9886" last="9893">
<title>Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy.</title>
<authorList>
<person name="Spencer A.G."/>
<person name="Woods J.W."/>
<person name="Arakawa T."/>
<person name="Singer I.I."/>
<person name="Smith W.L."/>
</authorList>
<dbReference type="PubMed" id="9545330"/>
<dbReference type="DOI" id="10.1074/jbc.273.16.9886"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION BY IL1B AND LIPOPOLYSACCHARIDE</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="J. Exp. Med." volume="192" first="1197" last="1204">
<title>Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.</title>
<authorList>
<person name="Serhan C.N."/>
<person name="Clish C.B."/>
<person name="Brannon J."/>
<person name="Colgan S.P."/>
<person name="Chiang N."/>
<person name="Gronert K."/>
</authorList>
<dbReference type="PubMed" id="11034610"/>
<dbReference type="DOI" id="10.1084/jem.192.8.1197"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Physiol. Pharmacol." volume="51" first="643" last="654">
<title>Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.</title>
<authorList>
<person name="Serhan C.N."/>
<person name="Clish C.B."/>
<person name="Brannon J."/>
<person name="Colgan S.P."/>
<person name="Gronert K."/>
<person name="Chiang N."/>
</authorList>
<dbReference type="PubMed" id="11192938"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Biochem. J." volume="365" first="489" last="496">
<title>Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.</title>
<authorList>
<person name="Levin G."/>
<person name="Duffin K.L."/>
<person name="Obukowicz M.G."/>
<person name="Hummert S.L."/>
<person name="Fujiwara H."/>
<person name="Needleman P."/>
<person name="Raz A."/>
</authorList>
<dbReference type="PubMed" id="11939906"/>
<dbReference type="DOI" id="10.1042/bj20011798"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Exp. Med." volume="196" first="1025" last="1037">
<title>Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.</title>
<authorList>
<person name="Serhan C.N."/>
<person name="Hong S."/>
<person name="Gronert K."/>
<person name="Colgan S.P."/>
<person name="Devchand P.R."/>
<person name="Mirick G."/>
<person name="Moussignac R.L."/>
</authorList>
<dbReference type="PubMed" id="12391014"/>
<dbReference type="DOI" id="10.1084/jem.20020760"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Science" volume="310" first="1966" last="1970">
<title>Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2.</title>
<authorList>
<person name="Kim S.F."/>
<person name="Huri D.A."/>
<person name="Snyder S.H."/>
</authorList>
<dbReference type="PubMed" id="16373578"/>
<dbReference type="DOI" id="10.1126/science.1119407"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>S-NITROSYLATION AT CYS-526</scope>
<scope>MUTAGENESIS OF CYS-526; CYS-555 AND CYS-561</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="FEBS Lett." volume="580" first="6533" last="6536">
<title>Glycosylation regulates turnover of cyclooxygenase-2.</title>
<authorList>
<person name="Sevigny M.B."/>
<person name="Li C.F."/>
<person name="Alas M."/>
<person name="Hughes-Fulford M."/>
</authorList>
<dbReference type="PubMed" id="17113084"/>
<dbReference type="DOI" id="10.1016/j.febslet.2006.10.073"/>
</citation>
<scope>GLYCOSYLATION AT ASN-580</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="J. Clin. Invest." volume="121" first="569" last="581">
<title>Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.</title>
<authorList>
<person name="Oh S.F."/>
<person name="Pillai P.S."/>
<person name="Recchiuti A."/>
<person name="Yang R."/>
<person name="Serhan C.N."/>
</authorList>
<dbReference type="PubMed" id="21206090"/>
<dbReference type="DOI" id="10.1172/jci42545"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="37383" last="37394">
<title>Prostaglandin H synthase-2-catalyzed oxygenation of 2-arachidonoylglycerol is more sensitive to peroxide tone than oxygenation of arachidonic acid.</title>
<authorList>
<person name="Musee J."/>
<person name="Marnett L.J."/>
</authorList>
<dbReference type="PubMed" id="22942274"/>
<dbReference type="DOI" id="10.1074/jbc.m112.381202"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="J. Lipid Res." volume="53" first="87" last="94">
<title>COX-2-dependent and -independent biosynthesis of dihydroxy-arachidonic acids in activated human leukocytes.</title>
<authorList>
<person name="Tejera N."/>
<person name="Boeglin W.E."/>
<person name="Suzuki T."/>
<person name="Schneider C."/>
</authorList>
<dbReference type="PubMed" id="22068350"/>
<dbReference type="DOI" id="10.1194/jlr.m017822"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="Biochem. Biophys. Res. Commun." volume="465" first="528" last="533">
<title>Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway.</title>
<authorList>
<person name="Kuwata H."/>
<person name="Hara S."/>
</authorList>
<dbReference type="PubMed" id="26282205"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2015.08.054"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INDUCTION BY IL1B</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Nat. Med." volume="21" first="1071" last="1075">
<title>Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections.</title>
<authorList>
<person name="Dalli J."/>
<person name="Chiang N."/>
<person name="Serhan C.N."/>
</authorList>
<dbReference type="PubMed" id="26236990"/>
<dbReference type="DOI" id="10.1038/nm.3911"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2016" name="Cell Chem. Biol." volume="23" first="1217" last="1227">
<title>Cyclooxygenase-2 Mediated Oxidation of 2-Arachidonoyl-Lysophospholipids Identifies Unknown Lipid Signaling Pathways.</title>
<authorList>
<person name="Liu X."/>
<person name="Moon S.H."/>
<person name="Jenkins C.M."/>
<person name="Sims H.F."/>
<person name="Gross R.W."/>
</authorList>
<dbReference type="PubMed" id="27642067"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2016.08.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="Annu. Rev. Biochem." volume="69" first="145" last="182">
<title>Cyclooxygenases: structural, cellular, and molecular biology.</title>
<authorList>
<person name="Smith W.L."/>
<person name="DeWitt D.L."/>
<person name="Garavito R.M."/>
</authorList>
<dbReference type="PubMed" id="10966456"/>
<dbReference type="DOI" id="10.1146/annurev.biochem.69.1.145"/>
</citation>
<scope>REVIEW ON FUNCTION; TISSUE SPECIFICITY AND INHIBITION BY NSAIDS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Prostaglandins Leukot. Essent. Fatty Acids" volume="81" first="165" last="170">
<title>The essentiality of arachidonic acid and docosahexaenoic acid.</title>
<authorList>
<person name="Le H.D."/>
<person name="Meisel J.A."/>
<person name="de Meijer V.E."/>
<person name="Gura K.M."/>
<person name="Puder M."/>
</authorList>
<dbReference type="PubMed" id="19540099"/>
<dbReference type="DOI" id="10.1016/j.plefa.2009.05.020"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="World J. Gastrointest. Pharmacol. Ther." volume="5" first="40" last="49">
<title>Aspirin, cyclooxygenase inhibition and colorectal cancer.</title>
<authorList>
<person name="Sostres C."/>
<person name="Gargallo C.J."/>
<person name="Lanas A."/>
</authorList>
<dbReference type="PubMed" id="24605250"/>
<dbReference type="DOI" id="10.4292/wjgpt.v5.i1.40"/>
</citation>
<scope>REVIEW ON FUNCTION; INHIBITION BY ASPIRIN AND INVOLVEMENT IN COLORECTAL CANCER</scope>
</reference>
<reference key="32" evidence="7">
<citation type="journal article" date="2016" name="Acta Crystallogr. F" volume="72" first="772" last="776">
<title>Crystal structure of rofecoxib bound to human cyclooxygenase-2.</title>
<authorList>
<person name="Orlando B.J."/>
<person name="Malkowski M.G."/>
</authorList>
<dbReference type="PubMed" id="27710942"/>
<dbReference type="DOI" id="10.1107/s2053230x16014230"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 19-569 IN COMPLEX WITH PROTOPORPHYRIN IX AND ROFECOXIB</scope>
<scope>COFACTOR</scope>
<scope>GLYCOSYLATION AT ASN-130 AND ASN-396</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="33" evidence="1 2">
<citation type="journal article" date="2016" name="Biochemistry" volume="55" first="1226" last="1238">
<title>Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.</title>
<authorList>
<person name="Lucido M.J."/>
<person name="Orlando B.J."/>
<person name="Vecchio A.J."/>
<person name="Malkowski M.G."/>
</authorList>
<dbReference type="PubMed" id="26859324"/>
<dbReference type="DOI" id="10.1021/acs.biochem.5b01378"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) OF 19-569 IN COMPLEX WITH PROTOPORPHYRIN IX AND SALICYLIC ACID</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF SER-516 AND GLY-519</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>GLYCOSYLATION AT ASN-53; ASN-130 AND ASN-396</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="34" evidence="3 4 5 6">
<citation type="journal article" date="2016" name="J. Biol. Chem." volume="291" first="15069" last="15081">
<title>Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.</title>
<authorList>
<person name="Orlando B.J."/>
<person name="Malkowski M.G."/>
</authorList>
<dbReference type="PubMed" id="27226593"/>
<dbReference type="DOI" id="10.1074/jbc.m116.725713"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.34 ANGSTROMS) OF 19-569 IN COMPLEX WITH PROTOPORPHYRIN IX AND FLUFENAMIC ACID</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>COFACTOR</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION AT ASN-53; ASN-130 AND ASN-396</scope>
<scope>DISULFIDE BONDS</scope>
<scope>MUTAGENESIS OF TYR-371 AND SER-516</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="Carcinogenesis" volume="25" first="2467" last="2472">
<title>Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk.</title>
<authorList>
<person name="Goodman J.E."/>
<person name="Bowman E.D."/>
<person name="Chanock S.J."/>
<person name="Alberg A.J."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="15308583"/>
<dbReference type="DOI" id="10.1093/carcin/bgh260"/>
</citation>
<scope>VARIANT ALA-511</scope>
</reference>
<comment type="function">
<text evidence="8 12 13 14 15 17 19 20 21 22 23 24 25 26 28 29 30 31 34">Dual cyclooxygenase and peroxidase in the biosynthesis pathway of prostanoids, a class of C20 oxylipins mainly derived from arachidonate, with a particular role in the inflammatory response (PubMed:7947975, PubMed:7592599, PubMed:9261177, PubMed:16373578, PubMed:22942274, PubMed:26859324, PubMed:27226593, PubMed:11939906, PubMed:19540099). The cyclooxygenase activity oxygenates arachidonate (AA, C20:4(n-6)) to the hydroperoxy endoperoxide prostaglandin G2 (PGG2), and the peroxidase activity reduces PGG2 to the hydroxy endoperoxide PGH2, the precursor of all 2-series prostaglandins and thromboxanes (PubMed:7947975, PubMed:7592599, PubMed:9261177, PubMed:16373578, PubMed:22942274, PubMed:26859324, PubMed:27226593). This complex transformation is initiated by abstraction of hydrogen at carbon 13 (with S-stereochemistry), followed by insertion of molecular O2 to form the endoperoxide bridge between carbon 9 and 11 that defines prostaglandins. The insertion of a second molecule of O2 (bis-oxygenase activity) yields a hydroperoxy group in PGG2 that is then reduced to PGH2 by two electrons (PubMed:7947975, PubMed:7592599, PubMed:9261177, PubMed:16373578, PubMed:22942274, PubMed:26859324, PubMed:27226593). Similarly catalyzes successive cyclooxygenation and peroxidation of dihomo-gamma-linoleate (DGLA, C20:3(n-6)) and eicosapentaenoate (EPA, C20:5(n-3)) to corresponding PGH1 and PGH3, the precursors of 1- and 3-series prostaglandins (PubMed:11939906, PubMed:19540099). In an alternative pathway of prostanoid biosynthesis, converts 2-arachidonoyl lysophopholipids to prostanoid lysophopholipids, which are then hydrolyzed by intracellular phospholipases to release free prostanoids (PubMed:27642067). Metabolizes 2-arachidonoyl glycerol yielding the glyceryl ester of PGH2, a process that can contribute to pain response (PubMed:22942274). Generates lipid mediators from n-3 and n-6 polyunsaturated fatty acids (PUFAs) via a lipoxygenase-type mechanism. Oxygenates PUFAs to hydroperoxy compounds and then reduces them to corresponding alcohols (PubMed:11034610, PubMed:11192938, PubMed:9048568, PubMed:9261177). Plays a role in the generation of resolution phase interaction products (resolvins) during both sterile and infectious inflammation (PubMed:12391014). Metabolizes docosahexaenoate (DHA, C22:6(n-3)) to 17R-HDHA, a precursor of the D-series resolvins (RvDs) (PubMed:12391014). As a component of the biosynthetic pathway of E-series resolvins (RvEs), converts eicosapentaenoate (EPA, C20:5(n-3)) primarily to 18S-HEPE that is further metabolized by ALOX5 and LTA4H to generate 18S-RvE1 and 18S-RvE2 (PubMed:21206090). In vascular endothelial cells, converts docosapentaenoate (DPA, C22:5(n-3)) to 13R-HDPA, a precursor for 13-series resolvins (RvTs) shown to activate macrophage phagocytosis during bacterial infection (PubMed:26236990). In activated leukocytes, contributes to oxygenation of hydroxyeicosatetraenoates (HETE) to diHETES (5,15-diHETE and 5,11-diHETE) (PubMed:22068350, PubMed:26282205). During neuroinflammation, plays a role in neuronal secretion of specialized preresolving mediators (SPMs) 15R-lipoxin A4 that regulates phagocytic microglia (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="17 21 24 25 28 29 31">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + 2 O2 = A + H2O + prostaglandin H2</text>
<dbReference type="Rhea" id="RHEA:23728"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:57405"/>
<dbReference type="EC" id="1.14.99.1"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="40 43 46 47 49 50 52">
<dbReference type="Rhea" id="RHEA:23729"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="21 28 29 31">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + 2 O2 = prostaglandin G2</text>
<dbReference type="Rhea" id="RHEA:42596"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:82629"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="43 49 50 52">
<dbReference type="Rhea" id="RHEA:42597"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="21 28 29 31">
<text>AH2 + prostaglandin G2 = A + H2O + prostaglandin H2</text>
<dbReference type="Rhea" id="RHEA:42600"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:57405"/>
<dbReference type="ChEBI" id="CHEBI:82629"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="43 49 50 52">
<dbReference type="Rhea" id="RHEA:42601"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="34">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + 2 O2 = prostaglandin G3</text>
<dbReference type="Rhea" id="RHEA:50444"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:133133"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="34">
<dbReference type="Rhea" id="RHEA:50445"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="34">
<text>AH2 + prostaglandin G3 = A + H2O + prostaglandin H3</text>
<dbReference type="Rhea" id="RHEA:50448"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:133133"/>
<dbReference type="ChEBI" id="CHEBI:133134"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="34">
<dbReference type="Rhea" id="RHEA:50449"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>(8Z,11Z,14Z)-eicosatrienoate + 2 O2 = prostaglandin G1</text>
<dbReference type="Rhea" id="RHEA:50424"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:71589"/>
<dbReference type="ChEBI" id="CHEBI:133084"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="38">
<dbReference type="Rhea" id="RHEA:50425"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="14">
<text>AH2 + prostaglandin G1 = A + H2O + prostaglandin H1</text>
<dbReference type="Rhea" id="RHEA:50432"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:90793"/>
<dbReference type="ChEBI" id="CHEBI:133084"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="38">
<dbReference type="Rhea" id="RHEA:50433"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphoethanolamine + 2 O2 = 2-(prostaglandin G2)-sn-glycero-3-phosphoethanolamine</text>
<dbReference type="Rhea" id="RHEA:54204"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:76091"/>
<dbReference type="ChEBI" id="CHEBI:138098"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:54205"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(prostaglandin G2)-sn-glycero-3-phosphoethanolamine + AH2 = 2-(prostaglandin H2)-sn-glycero-3-phosphoethanolamine + A + H2O</text>
<dbReference type="Rhea" id="RHEA:54208"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:138098"/>
<dbReference type="ChEBI" id="CHEBI:138099"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:54209"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + 2 O2 = 2-(prostaglandin G2)-sn-glycero-3-phosphocholine</text>
<dbReference type="Rhea" id="RHEA:54212"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:76079"/>
<dbReference type="ChEBI" id="CHEBI:138100"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:54213"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(prostaglandin G2)-sn-glycero-3-phosphocholine + AH2 = 2-(prostaglandin H2)-sn-glycero-3-phosphocholine + A + H2O</text>
<dbReference type="Rhea" id="RHEA:54216"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:138100"/>
<dbReference type="ChEBI" id="CHEBI:138101"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:54217"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="31">
<text>(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + AH2 = (5Z,8Z,11Z,13E,15S)-hydroxyeicosatetraenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48856"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:57409"/>
<dbReference type="ChEBI" id="CHEBI:57446"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="52">
<dbReference type="Rhea" id="RHEA:48857"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + AH2 + O2 = 2-[(15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl]-sn-glycero-3-phosphocholine + A + H2O</text>
<dbReference type="Rhea" id="RHEA:53684"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:76079"/>
<dbReference type="ChEBI" id="CHEBI:137584"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:53685"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + AH2 + O2 = 2-[(15R)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl]-sn-glycero-3-phosphocholine + A + H2O</text>
<dbReference type="Rhea" id="RHEA:53680"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:76079"/>
<dbReference type="ChEBI" id="CHEBI:137583"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:53681"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="26">
<text>2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine + AH2 + O2 = 2-[(11R)-hydroxy-(5Z,8Z,12E,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine + A + H2O</text>
<dbReference type="Rhea" id="RHEA:53676"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:76079"/>
<dbReference type="ChEBI" id="CHEBI:137582"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="48">
<dbReference type="Rhea" id="RHEA:53677"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13">
<text>(9Z,12Z)-octadecadienoate + AH2 + O2 = 9-hydroxy-(10E,12Z)-octadecadienoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50864"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:30245"/>
<dbReference type="ChEBI" id="CHEBI:133820"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37">
<dbReference type="Rhea" id="RHEA:50865"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13">
<text>(9Z,12Z)-octadecadienoate + AH2 + O2 = 13-hydroxy-(9Z,11E)-octadecadienoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50860"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:30245"/>
<dbReference type="ChEBI" id="CHEBI:133819"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37">
<dbReference type="Rhea" id="RHEA:50861"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (15R)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50856"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:78837"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37">
<dbReference type="Rhea" id="RHEA:50857"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (11R)-hydroxy-(5Z,8Z,12E,14Z)-eicosatetraenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50852"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:78836"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37">
<dbReference type="Rhea" id="RHEA:50853"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (11R)-hydroxy-(5Z,8Z,12E,14Z,17Z)-eicosapentaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50848"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:90820"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37">
<dbReference type="Rhea" id="RHEA:50849"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (18S)-hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50200"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:132083"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="41">
<dbReference type="Rhea" id="RHEA:50201"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13 19">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (18R)-hydroxy-(5Z,8Z,11Z,14Z,16E)-eicosapentaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48836"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:90818"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37 41">
<dbReference type="Rhea" id="RHEA:48837"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 13 19">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (15R)-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48840"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:90819"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="36 37 41">
<dbReference type="Rhea" id="RHEA:48841"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="19">
<text>(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + AH2 + O2 = (15S)-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:50196"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:58562"/>
<dbReference type="ChEBI" id="CHEBI:132087"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="41">
<dbReference type="Rhea" id="RHEA:50197"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="22">
<text>(7Z,10Z,13Z,16Z,19Z)-docosapentaenoate + AH2 + O2 = 13R-hydroxy-(7Z,10Z,14E,16Z,19Z)-docosapentaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48852"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:77224"/>
<dbReference type="ChEBI" id="CHEBI:90824"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="44">
<dbReference type="Rhea" id="RHEA:48853"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + AH2 + O2 = 13-hydroxy-(4Z,7Z,10Z,14E,16Z,19Z)-docosahexaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48820"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:77016"/>
<dbReference type="ChEBI" id="CHEBI:90815"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="39">
<dbReference type="Rhea" id="RHEA:48821"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="20">
<text>(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (5S,15R)-dihydroxy-(6E,8Z,11Z,13E)-eicosatetraenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48812"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:90632"/>
<dbReference type="ChEBI" id="CHEBI:90812"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="42">
<dbReference type="Rhea" id="RHEA:48813"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="15">
<text>(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + AH2 + O2 = 17R-hydroxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48816"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:77016"/>
<dbReference type="ChEBI" id="CHEBI:90814"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="39">
<dbReference type="Rhea" id="RHEA:48817"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="20">
<text>(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (5S,15S)-dihydroxy-(6E,8Z,11Z,13E)-eicosatetraenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48808"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:90632"/>
<dbReference type="ChEBI" id="CHEBI:90813"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="42">
<dbReference type="Rhea" id="RHEA:48809"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="20 23">
<text>(5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + AH2 + O2 = (5S,11R)-dihydroxy-(6E,8Z,12E,14Z)-eicosatetraenoate + A + H2O</text>
<dbReference type="Rhea" id="RHEA:48804"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:90632"/>
<dbReference type="ChEBI" id="CHEBI:90810"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="42 45">
<dbReference type="Rhea" id="RHEA:48805"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="21">
<text>2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + 2 O2 = 2-glyceryl-prostaglandin G2</text>
<dbReference type="Rhea" id="RHEA:45288"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:52392"/>
<dbReference type="ChEBI" id="CHEBI:85165"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="43">
<dbReference type="Rhea" id="RHEA:45289"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="21">
<text>2-glyceryl-prostaglandin G2 + AH2 = 2-glyceryl-prostaglandin H2 + A + H2O</text>
<dbReference type="Rhea" id="RHEA:45292"/>
<dbReference type="ChEBI" id="CHEBI:13193"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17499"/>
<dbReference type="ChEBI" id="CHEBI:85165"/>
<dbReference type="ChEBI" id="CHEBI:85166"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="43">
<dbReference type="Rhea" id="RHEA:45293"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="30">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = (15R)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:42284"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:82626"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="51">
<dbReference type="Rhea" id="RHEA:42285"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="30">
<text>(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = 11R-hydroperoxy-(5Z,8Z,12E,14Z)-eicosatetraenoate</text>
<dbReference type="Rhea" id="RHEA:42280"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:32395"/>
<dbReference type="ChEBI" id="CHEBI:82628"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="51">
<dbReference type="Rhea" id="RHEA:42281"/>
</physiologicalReaction>
</comment>
<comment type="cofactor">
<cofactor evidence="24 25 27">
<name>heme b</name>
<dbReference type="ChEBI" id="CHEBI:60344"/>
</cofactor>
<text evidence="24 25 27">Binds 1 heme b (iron(II)-protoporphyrin IX) group per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="12 13 15 19 20 22 30">The cyclooxygenase activity is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin, ibuprofen, flurbiprofen, celecoxib, flufenamic, mefenamic and tolfenamic acids as well as by hydroperoxide scavenger erythrocyte glutathione peroxidase GPX1 (PubMed:26859324, PubMed:27226593, PubMed:7592599, PubMed:9048568). Aspirin triggers enzyme acetylation turning off its ability to generate proinflammatory prostaglandins, but switches on its capacity to produce anti-inflammatory lipid mediators involved in inflammation resolution (PubMed:11034610, PubMed:12391014). Aspirin enhances lipoxygenase-type activity toward production of epimers with R stereochemistry such as 15R-HETE, 18R-HEPE, 15R-HEPE and 17R-HDHA (PubMed:11034610, PubMed:11192938, PubMed:22068350, PubMed:12391014, PubMed:9048568, PubMed:21206090). Atorvastatin, a cholesterol-lowering drug, triggers enzyme S-nitrosylation increasing production of 13-series resolvins (RvTs) (PubMed:26236990).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="17">16.2 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (in absence of sodium nitroprusside NO donor)</KM>
<KM evidence="24">12 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate</KM>
<KM evidence="17">17.0 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (in presence of sodium nitroprusside NO donor)</KM>
<KM evidence="29">5.1 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (cyclooxygenase and peroxidase activities)</KM>
<KM evidence="22">3.1 uM for (7Z,10Z,13Z,16Z,19Z)-docosapentaenoate</KM>
<KM evidence="30">0.93 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (cyclooxygenase activity)</KM>
<KM evidence="30">13 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (cyclooxygenase activity in presence of aspirin)</KM>
<KM evidence="30">41 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (lipoxygenase activity)</KM>
<KM evidence="30">15 uM for (5Z,8Z,11Z,14Z)-eicosatetraenoate (lipoxygenase activity in presence of aspirin)</KM>
<KM evidence="26">12.3 uM for 2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine (oxidation to 11-HETE-LPC)</KM>
<KM evidence="26">30 uM for 2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphocholine (oxidation to 15-HETE-LPC)</KM>
<Vmax evidence="17">81.3 nmol/min/mg enzyme (in absence of sodium nitroprusside NO donor)</Vmax>
<Vmax evidence="17">132 nmol/min/mg enzyme (in absence of sodium nitroprusside NO donor)</Vmax>
</kinetics>
</comment>
<comment type="pathway" evidence="24 25">
<text>Lipid metabolism; prostaglandin biosynthesis.</text>
</comment>
<comment type="subunit">
<text evidence="24 25">Homodimer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="32">Microsome membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Endoplasmic reticulum membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Nucleus inner membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="32">Nucleus outer membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="32">Detected on the lumenal side of the endoplasmic reticulum and nuclear envelope.</text>
</comment>
<comment type="induction">
<text evidence="23 32">By cytokines and mitogens. Up-regulated by IL1B (PubMed:26282205, PubMed:9545330). Up-regulated by lipopolysaccharide (LPS) (PubMed:9545330).</text>
</comment>
<comment type="PTM">
<text evidence="17">S-nitrosylation by NOS2 (iNOS) activates enzyme activity. S-nitrosylation may take place on different Cys residues in addition to Cys-526.</text>
</comment>
<comment type="PTM">
<text evidence="8">Acetylated at Ser-565 by SPHK1. During neuroinflammation, acetylation by SPHK1 promotes neuronal secretion of specialized preresolving mediators (SPMs), especially 15-R-lipoxin A4, which results in an increase of phagocytic microglia.</text>
</comment>
<comment type="miscellaneous">
<text>The conversion of arachidonate to prostaglandin H2 is a 2 step reaction: a cyclooxygenase (COX) reaction which converts arachidonate to prostaglandin G2 (PGG2) and a peroxidase reaction in which PGG2 is reduced to prostaglandin H2 (PGH2). The cyclooxygenase reaction occurs in a hydrophobic channel in the core of the enzyme. The peroxidase reaction occurs at a heme-containing active site located near the protein surface. The nonsteroidal anti-inflammatory drugs (NSAIDs) binding site corresponds to the cyclooxygenase active site.</text>
</comment>
<comment type="miscellaneous">
<text>Conversion of arachidonate to prostaglandin H2 is mediated by 2 different isozymes: the constitutive PTGS1 and the inducible PTGS2. PTGS1 is expressed constitutively and generally produces prostanoids acutely in response to hormonal stimuli to fine-tune physiological processes requiring instantaneous, continuous regulation (e.g. hemostasis). PTGS2 is inducible and typically produces prostanoids that mediate responses to physiological stresses such as infection and inflammation.</text>
</comment>
<comment type="miscellaneous">
<text evidence="24 25 27">PTGS1 and PTGS2 are the targets of nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin and ibuprofen (PubMed:27710942, PubMed:26859324, PubMed:27226593). Aspirin is able to produce an irreversible inactivation of the enzyme through a serine acetylation (PubMed:26859324). Inhibition of the PGHSs with NSAIDs acutely reduces inflammation, pain, and fever, and long-term use of these drugs reduces fatal thrombotic events, as well as the development of colon cancer and Alzheimer's disease. PTGS2 is the principal isozyme responsible for production of inflammatory prostaglandins. New generation PTGSs inhibitors strive to be selective for PTGS2, to avoid side effects such as gastrointestinal complications and ulceration.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the prostaglandin G/H synthase family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PTGS2ID509ch1q31.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/ptgs2/"/>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ptgs2/"/>
</comment>
<dbReference type="EC" id="1.14.99.1" evidence="17 24 25"/>
<dbReference type="EMBL" id="L15326">
<property type="protein sequence ID" value="AAA35803.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M90100">
<property type="protein sequence ID" value="AAA58433.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D28235">
<property type="protein sequence ID" value="BAA05698.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U04636">
<property type="protein sequence ID" value="AAA57317.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY462100">
<property type="protein sequence ID" value="AAR23927.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY229989">
<property type="protein sequence ID" value="AAO38056.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY382629">
<property type="protein sequence ID" value="AAQ75702.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292167">
<property type="protein sequence ID" value="BAF84856.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL033533">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471067">
<property type="protein sequence ID" value="EAW91216.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013734">
<property type="protein sequence ID" value="AAH13734.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1371.1"/>
<dbReference type="PIR" id="A46150">
<property type="entry name" value="A46150"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000954.1">
<property type="nucleotide sequence ID" value="NM_000963.3"/>
</dbReference>
<dbReference type="PDB" id="1V0X">
<property type="method" value="Model"/>
<property type="chains" value="A=1-604"/>
</dbReference>
<dbReference type="PDB" id="5F19">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.04"/>
<property type="chains" value="A/B=19-569"/>
</dbReference>
<dbReference type="PDB" id="5F1A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="A/B=19-570"/>
</dbReference>
<dbReference type="PDB" id="5IKQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="A/B=19-569"/>
</dbReference>
<dbReference type="PDB" id="5IKR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.34"/>
<property type="chains" value="A/B=19-569"/>
</dbReference>
<dbReference type="PDB" id="5IKT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=19-569"/>
</dbReference>
<dbReference type="PDB" id="5IKV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A/B=19-569"/>
</dbReference>
<dbReference type="PDB" id="5KIR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=19-569"/>
</dbReference>
<dbReference type="PDBsum" id="1V0X"/>
<dbReference type="PDBsum" id="5F19"/>
<dbReference type="PDBsum" id="5F1A"/>
<dbReference type="PDBsum" id="5IKQ"/>
<dbReference type="PDBsum" id="5IKR"/>
<dbReference type="PDBsum" id="5IKT"/>
<dbReference type="PDBsum" id="5IKV"/>
<dbReference type="PDBsum" id="5KIR"/>
<dbReference type="SMR" id="P35354"/>
<dbReference type="BioGRID" id="111715">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="CORUM" id="P35354"/>
<dbReference type="DIP" id="DIP-28131N"/>
<dbReference type="IntAct" id="P35354">
<property type="interactions" value="5"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000356438"/>
<dbReference type="BindingDB" id="P35354"/>
<dbReference type="ChEMBL" id="CHEMBL230"/>
<dbReference type="DrugBank" id="DB03477">
<property type="generic name" value="1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB06736">
<property type="generic name" value="Aceclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB13783">
<property type="generic name" value="Acemetacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00316">
<property type="generic name" value="Acetaminophen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB13167">
<property type="generic name" value="Alclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00041">
<property type="generic name" value="Aldesleukin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00233">
<property type="generic name" value="Aminosalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01435">
<property type="generic name" value="Antipyrine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01419">
<property type="generic name" value="Antrafenine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01014">
<property type="generic name" value="Balsalazide"/>
</dbReference>
<dbReference type="DrugBank" id="DB13501">
<property type="generic name" value="Bendazac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00963">
<property type="generic name" value="Bromfenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB13346">
<property type="generic name" value="Bufexamac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00887">
<property type="generic name" value="Bumetanide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09061">
<property type="generic name" value="Cannabidiol"/>
</dbReference>
<dbReference type="DrugBank" id="DB06774">
<property type="generic name" value="Capsaicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00821">
<property type="generic name" value="Carprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00482">
<property type="generic name" value="Celecoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00856">
<property type="generic name" value="Chlorphenesin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01401">
<property type="generic name" value="Choline magnesium trisalicylate"/>
</dbReference>
<dbReference type="DrugBank" id="DB05095">
<property type="generic name" value="Cimicoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00515">
<property type="generic name" value="Cisplatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00720">
<property type="generic name" value="Clodronic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00250">
<property type="generic name" value="Dapsone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00035">
<property type="generic name" value="Desmopressin"/>
</dbReference>
<dbReference type="DrugBank" id="DB09213">
<property type="generic name" value="Dexibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB09214">
<property type="generic name" value="Dexketoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00586">
<property type="generic name" value="Diclofenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00861">
<property type="generic name" value="Diflunisal"/>
</dbReference>
<dbReference type="DrugBank" id="DB00154">
<property type="generic name" value="Dihomo-gamma-linolenic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB11327">
<property type="generic name" value="Dipyrithione"/>
</dbReference>
<dbReference type="DrugBank" id="DB01395">
<property type="generic name" value="Drospirenone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09215">
<property type="generic name" value="Droxicam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00749">
<property type="generic name" value="Etodolac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00773">
<property type="generic name" value="Etoposide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01628">
<property type="generic name" value="Etoricoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00573">
<property type="generic name" value="Fenoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB09217">
<property type="generic name" value="Firocoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB13961">
<property type="generic name" value="Fish oil"/>
</dbReference>
<dbReference type="DrugBank" id="DB02266">
<property type="generic name" value="Flufenamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00712">
<property type="generic name" value="Flurbiprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01404">
<property type="generic name" value="Ginseng"/>
</dbReference>
<dbReference type="DrugBank" id="DB11323">
<property type="generic name" value="Glycol salicylate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01050">
<property type="generic name" value="Ibuprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00159">
<property type="generic name" value="Icosapent"/>
</dbReference>
<dbReference type="DrugBank" id="DB00328">
<property type="generic name" value="Indomethacin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01009">
<property type="generic name" value="Ketoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00465">
<property type="generic name" value="Ketorolac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00480">
<property type="generic name" value="Lenalidomide"/>
</dbReference>
<dbReference type="DrugBank" id="DB04725">
<property type="generic name" value="Licofelone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06725">
<property type="generic name" value="Lornoxicam"/>
</dbReference>
<dbReference type="DrugBank" id="DB09212">
<property type="generic name" value="Loxoprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB01283">
<property type="generic name" value="Lumiracoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01397">
<property type="generic name" value="Magnesium salicylate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00939">
<property type="generic name" value="Meclofenamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB14009">
<property type="generic name" value="Medical Cannabis"/>
</dbReference>
<dbReference type="DrugBank" id="DB00784">
<property type="generic name" value="Mefenamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00814">
<property type="generic name" value="Meloxicam"/>
</dbReference>
<dbReference type="DrugBank" id="DB11201">
<property type="generic name" value="Menthyl salicylate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00244">
<property type="generic name" value="Mesalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB09285">
<property type="generic name" value="Morniflumate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14011">
<property type="generic name" value="Nabiximols"/>
</dbReference>
<dbReference type="DrugBank" id="DB00461">
<property type="generic name" value="Nabumetone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00788">
<property type="generic name" value="Naproxen"/>
</dbReference>
<dbReference type="DrugBank" id="DB06802">
<property type="generic name" value="Nepafenac"/>
</dbReference>
<dbReference type="DrugBank" id="DB04552">
<property type="generic name" value="Niflumic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB04743">
<property type="generic name" value="Nimesulide"/>
</dbReference>
<dbReference type="DrugBank" id="DB06804">
<property type="generic name" value="Nonoxynol-9"/>
</dbReference>
<dbReference type="DrugBank" id="DB11133">
<property type="generic name" value="Omega-3 fatty acids"/>
</dbReference>
<dbReference type="DrugBank" id="DB13168">
<property type="generic name" value="Omega-6 fatty acids"/>
</dbReference>
<dbReference type="DrugBank" id="DB00991">
<property type="generic name" value="Oxaprozin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08439">
<property type="generic name" value="Parecoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB11071">
<property type="generic name" value="Phenyl salicylate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00812">
<property type="generic name" value="Phenylbutazone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00554">
<property type="generic name" value="Piroxicam"/>
</dbReference>
<dbReference type="DrugBank" id="DB08910">
<property type="generic name" value="Pomalidomide"/>
</dbReference>
<dbReference type="DrugBank" id="DB05804">
<property type="generic name" value="Prasterone sulfate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09288">
<property type="generic name" value="Propacetamol"/>
</dbReference>
<dbReference type="DrugBank" id="DB03866">
<property type="generic name" value="Prostaglandin G2"/>
</dbReference>
<dbReference type="DrugBank" id="DB02709">
<property type="generic name" value="Resveratrol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00884">
<property type="generic name" value="Risedronic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00533">
<property type="generic name" value="Rofecoxib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00936">
<property type="generic name" value="Salicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01399">
<property type="generic name" value="Salsalate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00360">
<property type="generic name" value="Sapropterin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05875">
<property type="generic name" value="Sar9, Met (O2)11-Substance P"/>
</dbReference>
<dbReference type="DrugBank" id="DB06195">
<property type="generic name" value="Seliciclib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06436">
<property type="generic name" value="Semaxanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00795">
<property type="generic name" value="Sulfasalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00605">
<property type="generic name" value="Sulindac"/>
</dbReference>
<dbReference type="DrugBank" id="DB00870">
<property type="generic name" value="Suprofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB08819">
<property type="generic name" value="Tafluprost"/>
</dbReference>
<dbReference type="DrugBank" id="DB09295">
<property type="generic name" value="Talniflumate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00469">
<property type="generic name" value="Tenoxicam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01041">
<property type="generic name" value="Thalidomide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01600">
<property type="generic name" value="Tiaprofenic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB09216">
<property type="generic name" value="Tolfenamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00500">
<property type="generic name" value="Tolmetin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00620">
<property type="generic name" value="Triamcinolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB11079">
<property type="generic name" value="Trolamine salicylate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00580">
<property type="generic name" value="Valdecoxib"/>
</dbReference>
<dbReference type="DrugCentral" id="P35354"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1376"/>
<dbReference type="SwissLipids" id="SLP:000000830"/>
<dbReference type="PeroxiBase" id="3321">
<property type="entry name" value="HsPGHS02"/>
</dbReference>
<dbReference type="GlyConnect" id="1649">
<property type="glycosylation" value="9 N-Linked glycans (3 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P35354">
<property type="glycosylation" value="6 sites, 3 N-linked glycans (2 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P35354"/>
<dbReference type="PhosphoSitePlus" id="P35354"/>
<dbReference type="BioMuta" id="PTGS2"/>
<dbReference type="DMDM" id="3915797"/>
<dbReference type="EPD" id="P35354"/>
<dbReference type="jPOST" id="P35354"/>
<dbReference type="MassIVE" id="P35354"/>
<dbReference type="MaxQB" id="P35354"/>
<dbReference type="PaxDb" id="P35354"/>
<dbReference type="PeptideAtlas" id="P35354"/>
<dbReference type="PRIDE" id="P35354"/>
<dbReference type="ProteomicsDB" id="55035"/>
<dbReference type="Antibodypedia" id="776">
<property type="antibodies" value="951 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5743"/>
<dbReference type="Ensembl" id="ENST00000367468">
<property type="protein sequence ID" value="ENSP00000356438"/>
<property type="gene ID" value="ENSG00000073756"/>
</dbReference>
<dbReference type="GeneID" id="5743"/>
<dbReference type="KEGG" id="hsa:5743"/>
<dbReference type="UCSC" id="uc001gsb.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5743"/>
<dbReference type="DisGeNET" id="5743"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000073756.11"/>
<dbReference type="GeneCards" id="PTGS2"/>
<dbReference type="HGNC" id="HGNC:9605">
<property type="gene designation" value="PTGS2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000073756">
<property type="expression patterns" value="Group enriched (ductus deferens, seminal vesicle)"/>
</dbReference>
<dbReference type="MIM" id="600262">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P35354"/>
<dbReference type="OpenTargets" id="ENSG00000073756"/>
<dbReference type="PharmGKB" id="PA293"/>
<dbReference type="eggNOG" id="KOG2408">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000010743"/>
<dbReference type="HOGENOM" id="CLU_022428_0_0_1"/>
<dbReference type="InParanoid" id="P35354"/>
<dbReference type="KO" id="K11987"/>
<dbReference type="OMA" id="PTYNVHY"/>
<dbReference type="OrthoDB" id="180654at2759"/>
<dbReference type="PhylomeDB" id="P35354"/>
<dbReference type="TreeFam" id="TF329675"/>
<dbReference type="BioCyc" id="MetaCyc:HS01115-MONOMER"/>
<dbReference type="BRENDA" id="1.14.99.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P35354"/>
<dbReference type="Reactome" id="R-HSA-197264">
<property type="pathway name" value="Nicotinamide salvaging"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2142770">
<property type="pathway name" value="Synthesis of 15-eicosatetraenoic acid derivatives"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2162123">
<property type="pathway name" value="Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6783783">
<property type="pathway name" value="Interleukin-10 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018677">
<property type="pathway name" value="Biosynthesis of DHA-derived SPMs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018679">
<property type="pathway name" value="Biosynthesis of EPA-derived SPMs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9025094">
<property type="pathway name" value="Biosynthesis of DPAn-3 SPMs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9027604">
<property type="pathway name" value="Biosynthesis of electrophilic Omega-3 PUFA oxo-derivatives"/>
</dbReference>
<dbReference type="SABIO-RK" id="P35354"/>
<dbReference type="SIGNOR" id="P35354"/>
<dbReference type="UniPathway" id="UPA00662"/>
<dbReference type="BioGRID-ORCS" id="5743">
<property type="hits" value="1 hit in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PTGS2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Prostaglandin-endoperoxide_synthase_2"/>
<dbReference type="GeneWiki" id="PTGS2"/>
<dbReference type="GenomeRNAi" id="5743"/>
<dbReference type="Pharos" id="P35354">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P35354"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P35354">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000073756">
<property type="expression patterns" value="Expressed in seminal vesicle and 199 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P35354">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P35354">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005901">
<property type="term" value="C:caveola"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005637">
<property type="term" value="C:nuclear inner membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005640">
<property type="term" value="C:nuclear outer membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016702">
<property type="term" value="F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004601">
<property type="term" value="F:peroxidase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004666">
<property type="term" value="F:prostaglandin-endoperoxide synthase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030282">
<property type="term" value="P:bone mineralization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050873">
<property type="term" value="P:brown fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071318">
<property type="term" value="P:cellular response to ATP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071498">
<property type="term" value="P:cellular response to fluid shear stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034605">
<property type="term" value="P:cellular response to heat"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071284">
<property type="term" value="P:cellular response to lead ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071471">
<property type="term" value="P:cellular response to non-ionic osmotic stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019371">
<property type="term" value="P:cyclooxygenase pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046697">
<property type="term" value="P:decidualization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007566">
<property type="term" value="P:embryo implantation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042633">
<property type="term" value="P:hair cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007612">
<property type="term" value="P:learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019372">
<property type="term" value="P:lipoxygenase pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042759">
<property type="term" value="P:long-chain fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035633">
<property type="term" value="P:maintenance of blood-brain barrier"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007613">
<property type="term" value="P:memory"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034356">
<property type="term" value="P:NAD biosynthesis via nicotinamide riboside salvage pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097756">
<property type="term" value="P:negative regulation of blood vessel diameter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051926">
<property type="term" value="P:negative regulation of calcium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045786">
<property type="term" value="P:negative regulation of cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902219">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045986">
<property type="term" value="P:negative regulation of smooth muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032227">
<property type="term" value="P:negative regulation of synaptic transmission, dopaminergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030728">
<property type="term" value="P:ovulation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090336">
<property type="term" value="P:positive regulation of brown fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090050">
<property type="term" value="P:positive regulation of cell migration involved in sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031622">
<property type="term" value="P:positive regulation of fever generation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090271">
<property type="term" value="P:positive regulation of fibroblast growth factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090362">
<property type="term" value="P:positive regulation of platelet-derived growth factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031394">
<property type="term" value="P:positive regulation of prostaglandin biosynthetic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045987">
<property type="term" value="P:positive regulation of smooth muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031915">
<property type="term" value="P:positive regulation of synaptic plasticity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051968">
<property type="term" value="P:positive regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071636">
<property type="term" value="P:positive regulation of transforming growth factor beta production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001516">
<property type="term" value="P:prostaglandin biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008217">
<property type="term" value="P:regulation of blood pressure"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0150077">
<property type="term" value="P:regulation of neuroinflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990776">
<property type="term" value="P:response to angiotensin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070542">
<property type="term" value="P:response to fatty acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009750">
<property type="term" value="P:response to fructose"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051384">
<property type="term" value="P:response to glucocorticoid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010226">
<property type="term" value="P:response to lithium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010042">
<property type="term" value="P:response to manganese ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0034612">
<property type="term" value="P:response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033280">
<property type="term" value="P:response to vitamin D"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019233">
<property type="term" value="P:sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.640.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029576">
<property type="entry name" value="COX-2"/>
</dbReference>
<dbReference type="InterPro" id="IPR000742">
<property type="entry name" value="EGF-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR019791">
<property type="entry name" value="Haem_peroxidase_animal"/>
</dbReference>
<dbReference type="InterPro" id="IPR010255">
<property type="entry name" value="Haem_peroxidase_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR037120">
<property type="entry name" value="Haem_peroxidase_sf_animal"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11903:SF8">
<property type="entry name" value="PTHR11903:SF8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03098">
<property type="entry name" value="An_peroxidase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00008">
<property type="entry name" value="EGF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00457">
<property type="entry name" value="ANPEROXIDASE"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48113">
<property type="entry name" value="SSF48113"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50026">
<property type="entry name" value="EGF_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50292">
<property type="entry name" value="PEROXIDASE_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0223">Dioxygenase</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0275">Fatty acid biosynthesis</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0575">Peroxidase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0643">Prostaglandin biosynthesis</keyword>
<keyword id="KW-0644">Prostaglandin metabolism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="9">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="chain" description="Prostaglandin G/H synthase 2" id="PRO_0000023875">
<location>
<begin position="18"/>
<end position="604"/>
</location>
</feature>
<feature type="domain" description="EGF-like" evidence="10">
<location>
<begin position="18"/>
<end position="55"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="11">
<location>
<position position="193"/>
</location>
</feature>
<feature type="active site" description="For cyclooxygenase activity" evidence="8">
<location>
<position position="371"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)" evidence="11">
<location>
<position position="374"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="8">
<location>
<position position="106"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="8">
<location>
<position position="341"/>
</location>
</feature>
<feature type="site" description="Aspirin-acetylated serine" evidence="24">
<location>
<position position="516"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine" evidence="40">
<location>
<position position="526"/>
</location>
</feature>
<feature type="modified residue" description="O-acetylserine" evidence="8">
<location>
<position position="565"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 5 24 25">
<location>
<position position="53"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<position position="130"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<position position="396"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="580"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<begin position="21"/>
<end position="32"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<begin position="22"/>
<end position="145"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<begin position="26"/>
<end position="42"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<begin position="44"/>
<end position="54"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 6 7 24 25 27">
<location>
<begin position="555"/>
<end position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3218622." id="VAR_016262" evidence="33">
<original>R</original>
<variation>H</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4648279." id="VAR_016263" evidence="33">
<original>P</original>
<variation>A</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5272." id="VAR_011980">
<original>E</original>
<variation>G</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5273." id="VAR_011981" evidence="16 33">
<original>V</original>
<variation>A</variation>
<location>
<position position="511"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3218625." id="VAR_016264" evidence="33">
<original>G</original>
<variation>R</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases two-electron hydroperoxide reduction. Has no effect on cyclooxygenase activity." evidence="31">
<original>Q</original>
<variation>N</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs two-electron hydroperoxide reduction and cyclooxygenase activity." evidence="31">
<original>Q</original>
<variation>R</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs two-electron hydroperoxide reduction." evidence="31">
<original>Q</original>
<variation>V</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces two-electron hydroperoxide reduction and cyclooxygenase activity. Catalyzes predominantly one-electron hydroperoxide reduction." evidence="31">
<original>H</original>
<variation>A</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased protein stability. Increased decrease of protein stability; when associated with A-516." evidence="25">
<original>Y</original>
<variation>A</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on protein stability. Increased decrease of protein stability; when associated with A-371." evidence="25">
<original>S</original>
<variation>A</variation>
<location>
<position position="516"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased enzyme activity with arachidonic acid. Loss of cyclooxygenase activity; when associated with V-519." evidence="24">
<original>S</original>
<variation>T</variation>
<location>
<position position="516"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of cyclooxygenase activity. Loss of cyclooxygenase activity; when associated with T-516." evidence="24">
<original>G</original>
<variation>V</variation>
<location>
<position position="519"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents activation by nitric oxid (NO)." evidence="17">
<original>C</original>
<variation>S</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="17">
<original>C</original>
<variation>S</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect activation by nitric oxid (NO)." evidence="17">
<original>C</original>
<variation>S</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA58433." ref="2" evidence="35">
<original>E</original>
<variation>G</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA35803." ref="1" evidence="35">
<original>I</original>
<variation>T</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="20"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="35"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="47"/>
<end position="50"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="59"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="71"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="82"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="92"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="120"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="125"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="135"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="150"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="160"/>
<end position="167"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="182"/>
<end position="192"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="217"/>
<end position="220"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="224"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="241"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="246"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="282"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="311"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="334"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="349"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="365"/>
<end position="370"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="374"/>
<end position="376"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="379"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="386"/>
<end position="388"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="390"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="398"/>
<end position="414"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="420"/>
<end position="424"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="428"/>
<end position="430"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="431"/>
<end position="443"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="449"/>
<end position="455"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="464"/>
<end position="468"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="472"/>
<end position="481"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="484"/>
<end position="486"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="489"/>
<end position="495"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="506"/>
<end position="521"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="524"/>
<end position="526"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="528"/>
<end position="530"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="533"/>
<end position="536"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="539"/>
<end position="546"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="550"/>
<end position="557"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F19"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F1A"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IKQ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IKR"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IKT"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IKV"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KIR"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q05769"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00076"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00298"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11034610"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11192938"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11939906"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12391014"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15308583"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16373578"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17113084"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21206090"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22068350"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22942274"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26236990"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26282205"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26859324"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27226593"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27642067"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27710942"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7592599"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7947975"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9048568"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9261177"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9545330"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19540099"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11034610"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11192938"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11939906"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12391014"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16373578"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21206090"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22068350"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22942274"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26236990"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26282205"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26859324"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27226593"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27642067"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7592599"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7947975"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9048568"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9261177"/>
</source>
</evidence>
<sequence length="604" mass="68996" checksum="72FBD699F6128519" modified="1998-12-15" version="2" precursor="true">MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

